Skip to content

Released May 4, 2011, after the close

10-Q filed May 4, 2011, 34 days after period end · 0000950123-11-044803

Q1 2011 · 10-Q
Revenue—
Net Income-$5.05Mno prior Q1 2010 on fileno prior Q4 2010 on file
EPS Diluted$0.06no prior Q1 2010 on fileno prior Q4 2010 on file
Operating Cash Flow-$3,988,000—
Free Cash Flowderived-$6,592,000—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q1 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Protalix BioTherapeutics, Inc. · CIK 1006281 · Engraved from SEC EDGAR